Featured Research

from universities, journals, and other organizations

New Study Suggests An Unidentified Source As Cause Of Residual Viremia In HIV-1 Patients On HAART

Date:
August 31, 2009
Source:
American Society for Microbiology
Summary:
A new study suggests that an unidentified cellular source may be responsible for residual viremia in HIV-1 patients on highly active antiretroviral therapy (HAART). This discovery disputes previous theories that attributed residual viremia to latent proviruses in resting CD4+ T cells and could significantly impact eradication efforts.

A new study suggests that an unidentified cellular source may be responsible for residual viremia in HIV-1 patients on highly active antiretroviral therapy (HAART). This discovery disputes previous theories that attributed residual viremia to latent proviruses in resting CD4+ T cells and could significantly impact eradication efforts.

Related Articles


The researchers from The Johns Hopkins University School of Medicine, Baltimore, Maryland; The University of Texas, Austin; and the Howard Hughes Medical Institute, Baltimore, Maryland report their findings in the September 2009 issue of the Journal of Virology.

When successful, HAART can reduce HIV-1 levels in the blood to undetectable amounts, however, HIV-1 still persists as latent proviruses in resting CD4+ T cells, also known as residual viremia. Current eradication strategies have focused on these latent T cell reservoirs, however, treatment failure has prompted researchers to examine other cellular reservoirs as potential sources of residual viremia.

Using two different methods, researchers analyzed viral sequences from individual patients to determine whether residual viremia was stemming from a source other than latent resting CD4+ T cells. Results showed residual viremia to be genetically distinct from proviruses in activated CD4+ T cells.

"The finding that some of the residual viremia in patients on HAART stems from an unidentified cellular source other than CD4+ T cells has implications for eradication efforts," say the researchers.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. T.P. Brennan, J.O. Woods, A.R. Sedaghat, J.D. Siliciano, R.F. Siliciano, C.O. Wilke. Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4 T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy. Journal of Virology, 2009; 83 (17): 8470 DOI: 10.1128/JVI.02568-08

Cite This Page:

American Society for Microbiology. "New Study Suggests An Unidentified Source As Cause Of Residual Viremia In HIV-1 Patients On HAART." ScienceDaily. ScienceDaily, 31 August 2009. <www.sciencedaily.com/releases/2009/08/090825082656.htm>.
American Society for Microbiology. (2009, August 31). New Study Suggests An Unidentified Source As Cause Of Residual Viremia In HIV-1 Patients On HAART. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2009/08/090825082656.htm
American Society for Microbiology. "New Study Suggests An Unidentified Source As Cause Of Residual Viremia In HIV-1 Patients On HAART." ScienceDaily. www.sciencedaily.com/releases/2009/08/090825082656.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins